Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
JACC. Clinical Electrophysiology|October 25, 2024
Impact of Catheter Ablation on Atrial Fibrillation Burden and Symptoms in Patients With Hypertrophic CardiomyopathyNikhil Ahluwalia, Shohreh Honarbakhsh, Rangeena Assadi, et al.
Heart (British Cardiac Society)|October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysisConstantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
The New England Journal of Medicine|August 28, 2018
Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyMathew S Maurer, Jeffrey H Schwartz, Balarama Gundapaneni, et al.
Journal of the American College of Cardiology|August 27, 2025
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM TrialMilind Y Desai, Iacopo Olivotto, Theodore Abraham, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.
European Journal of Preventive Cardiology|November 1, 2024
Arrhythmic risk stratification in patients with left ventricular ring-like scarVanda Parisi, Maddalena Graziosi, Luis R Lopes, et al.
European Heart Journal|March 4, 2026
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term studyAlbree Tower-Rader, Ahmad Masri, Michael E Nassif, et al.
Pageof 24